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Abstract:   
Context:  Anterior cruciate ligament (ACL) reconstruction is a safe, common, and effective 
method of restoring stability to the knee after injury, but evolving techniques of reconstruction 
carry inherent risk.  Infection after ACL reconstruction, while rare, carries a high morbidity 
potentially resulting in poor clinical outcome.  
Evidence Acquisition:  Data were obtained from previously published peer-reviewed literature 
through a search of the entire PubMed database (up to December 2012) as well as from textbook 
chapters. 
Results:  Treatment with culture-specific antibiotics and debridement with graft retention is 
generally more effective than graft removal, but with persistent infection consideration should be 
given to graft removal.  Graft type likely has no effect on infection rates.  
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Conclusions:  The early diagnosis of infection and appropriate treatment are necessary to avoid 
the complications of articular cartilage damage and arthrofibrosis. 
Keywords: Anterior cruciate ligament, infection, graft type 
 
Introduction 
 Anterior cruciate ligament (ACL) rupture is the most frequent ligamentous injury of the 
knee (42).  It is frequently injured in the young athletes performing cutting and pivoting sports, 
and predisposes the knee to subsequent injuries, as well as the potential for earlier onset of 
osteoarthritis (15, 35, 51).  Arthroscopic ACL reconstruction is a common and effective method 
of restoring stability to the knee after injury, with more than 400,000 ACL reconstructions 
performed annually in the U.S.  (18, 40, 39, 26, 38, 43, 45, 46, 65, 79, 27).  Like any surgical 
procedure, a number of potential complications have been recognized that may affect functional 
outcome (41, 57, 12, 3, 69).  Specifically infection after ACL reconstruction can be a devastating 
complication.  Overall, infection rates are low after ACL reconstruction (58).  Despite theoretical 
risk of disease transmission and higher graft failure in irradiated grafts, the use of allograft tissue 
continues to gain popularity for a number of reasons.   
 
Allograft vs. Autograft: Clinical Outcomes 
Graft material has received a significant amount of attention when focusing on surgical 
variables (14).  The ideal graft would have low infection rates, low cost, low donor-site 
morbidity, fast incorporation, and wide availability.  Autograft reconstruction remains the gold 
standard for younger patients, and despite the frequency of reconstruction surgery there is 
considerable controversy and variability in graft selection.  No perfect graft exists.  The use of 
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allografts in ACL reconstruction has increased significantly as both surgeons and patients desire 
limited donor-site morbidity, ease of use, decreased operative time, lower incidence of 
postoperative arthrofibrosis, low residual muscle weakness, availability and variety of graft sizes, 
decreased postoperative pain, improved cosmetic appearance, and commencement of earlier 
rehabilitation with faster return to work (27, 80, 70, 11, 67).  Autograft harvest is not a 
completely benign event and has potential short and long-term morbidity, limiting options during 
procedural complications of graft harvest and revision reconstruction (5).  Desire to avoid the 
sacrifice of autologous tissue, as well as to minimize surgical trauma and postoperative donor-
site morbidity, has promoted consideration and increased use of allograft tissue.  Tissue 
autografts amenable for use include central third bone-patellar tendon-bone (BTB), 
semitendinosus-gracilis graft from the hamstring (HS), or quadriceps tendon graft. Allograft 
tissues include the tibialis anterior or posterior, BTB, Achilles tendon with bone plug, fascia lata, 
peroneus longus, HS, and quadriceps tendons.  Ultimately, graft selection is influenced by 
preoperative physical exam, patient age and activity level, as well as by the surgeon’s preference, 
experience, and bias (28).  A number of studies have demonstrated allograft efficacy in 
improving stability and function, and clinical outcomes comparable to reconstruction with 
autologous tissue, making them an acceptable alternative to autografts (32, 75, 52, 47, 81, 13, 
21).  Yet, other studies have suggested higher failure rates with allograft tissue (8, 55, 60, 16, 7, 
53, 71). While no consensus exists, allografts have been recommended for patients over 45 
because they permit quicker recovery when morbidity associated with graft procurement is 
eliminated (80).  
 
Allograft vs. Autograft: Incidence of Sepsis 
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 Allograft tissue has become an acceptable graft choice for ACL reconstruction, raising 
considerable questions regarding the risk of viral and bacterial transmission from contaminated 
tissue. Although the risk is low, these confirmed cases represent a major medical and surgical 
challenge.  To date there have been three reported incidences of viral disease transmission from 
bone-patellar tendon-bone allografts used to reconstruct the ACL.  One case of HIV was reported 
in 1995, and two cases of hepatitis C have been reported (82, 29, 76, 77, 25).  The American 
Association of Tissue Banks (AATB) recommends routine serologic screening for HIV, human 
T-cell leukemia virus, hepatitis B, hepatitis C, aerobic and anaerobic bacteria, and syphilis.  
Overall, the risk of HIV transmission with connective tissue allografts is estimated to be one in 
1.6 million (19, 17, 27). 
 The Center for Disease Control (CDC) and Prevention reported 26 cases of bacterial 
infections associated with musculoskeletal tissue allografts after the reported death of a recipient 
of an allograft (femoral condyle) contaminated with Clostridium.  Thirteen of the cases were 
infected with Clostridium, and fourteen were associated with a single tissue processor.  All were 
processed aseptically, but none underwent terminal sterilization.  The CDC also described two 
cases of septic arthritis following allograft ACL reconstructions from a common donor at a 
Texas-based tissue bank, and two from a common donor at a Florida-based tissue bank (23, 24).  
Completed sterilization techniques were confirmed from the Texas-based tissue bank, but 
sterilization procedures were mistakenly not performed on the tissue from the Florida-based 
tissue bank.  Tissue bank regulation has increased dramatically since the occurrence of these 
documented transmissions, and as of May 2005, all tissue banks in the United States were 
required to conform to the FDA’s “Good Tissue Practice” guidelines, which permit inspection of 
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tissue bank facilities and specify minimum standards for tissue recovery, testing, and processing 
(48).   
 Septic arthritis remains a rare but devastating complication following ACL 
reconstruction.  Reports in the literature show an incidence of 0.14% to 1.70% (20, 33, 44, 59, 
86, 88).  Reports evaluating the difference in the rates of postoperative infection with allografts 
versus autografts are limited, and the current literature provides conflicting data.  Using the 
PubMed database we sought to study the largest available trials that specifically investigated the 
incidence of infection in allograft and autograft ACL reconstruction (Table 1).  Some papers 
have suggested no difference in infection rates between allo- and autograft.  Barker et al. 
reviewed 3,126 ACL reconstructions with 1,777 autografts and 1,349 allografts, finding infection 
rates of 0.44% in allografts and 0.68% in autografts (6).  Although their infection rates were 
lower, Indelli et al also found no significant difference between allograft and autograft (44).  
They reviewed 3,500 arthroscopic ACL reconstructions and found infection rates of 0.29% 
(4/1,400) for BTB autograft and 0.1% (2/2,100) for allograft.  Greenberg et al examined 861 
patients and found no infections in either group (36).   Our research has also suggested no 
difference as well (34).  We looked at 788 ACL reconstructions, 535 allograft and 253 autograft, 
with infection rates of 0.74% (four patients) and 0.79% (two patients), respectively.  
Conversely, several studies have reported differences in the rates of infection associated 
with graft type.  Katz et al showed an increased rate of infection among autografts (1.2%) versus 
allografts (0.63%), but it was not statistically significant (50).  Explanation for this trend toward 
a higher infection rate in the autograft population included longer surgical time, more invasive 
tissue dissection, and longer preparation of graft.  Furthermore, the same type of “tube-within-a-
tube” tissue harvester suspected by Tuman et al. as a source of contamination when not 
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disassembled during sterilization was used during their study (83).  Meanwhile, data reported by 
both Wang et al and Crawford et al suggested a higher rate of infection in allograft tissue than 
autograft tissue (Wang 1.11% versus 0.5%; Crawford 3.8% versus 0%, respectively) (87, 30).   
Both of these studies have their flaws.  In the study by Wang et al, the one infection in 90 
allograft reconstructions skewed their results when compared to 20 infections in 3,978 
autografts.  The Crawford et al study reported 11 infections in 290 allografts (3.8%) in which 
none of the allografts had undergone sterilization procedures, and no infections in 41 autografts.  
These seven studies represent the largest series comparing infection rates in allografts with 
autografts.  As shown in Table 1, pooling these data together to include over 13,000 
reconstructions shows infection rates for autograft and allografts to be 0.51% and 0.49%, 
respectively.    
 Although it has been hypothesized that allograft contamination has the potential for 
disease transmission, the link between contaminated grafts and clinical infections has been called 
into question.  Guelich et al evaluated the utility of culturing allografts, demonstrating a positive 
bacterial culture rate of 9.7% (24 of 247 allografts) (37).  These patients did not receive 
antibiotics in addition to the routine use of preoperative prophylactic antibiotics, and none went 
on to develop septic arthritis or wound complications.  Likewise, Diaz-de-Rada et al, had 24 
positive cultures from 181 allograft implantations analyzed; no patients showed clinical infection 
during follow-up (31).  Hence, culture positive evidence of allograft contamination did not 
correlate with infectious complications (22). 
 
Autograft: Bone-patella tendon-bone vs. hamstring incidence of sepsis 
7 
 
 Some reports suggest an increased rate of infection with hamstring tendon autograft as 
compared with BTB autograft.  Barker et al had 18 cases of septic arthritis after ACL 
reconstruction, there was a statistically significant increased risk of infection with hamstring 
tendon autograft (1.44%) compared with BTB autograft (0.49%) (6).  Other studies have 
demonstrated a trend toward increased risk with hamstrings, but have not achieved statistical 
significance.  In one of the largest reports, Wang et al reviewed 21 cases of infection from a 
population of 4,068 patients with ACL reconstruction (87).  The majority of reconstructions were 
performed using autografts, and 20 (0.57%) infections occurred among 3536 patients 
reconstructed with hamstrings; no infections occurred among 442 post BTB autografts.  A 
possible explanation included the frequent use of flash sterilization that was correlated with the 
occurrence of infections.  Judd et al found similar results in a review of 217 BTB autografts and 
192 hamstring autografts where all 11 intra-articular infections occurred in the hamstring group 
(49).  The high rate of infection among hamstring autografts was attributed to the choice of graft 
fixation or additional soft-tissue dissection rather than the graft itself.  Katz et al also had two of 
118 hamstring autograft infections and 0 of 52 BTB (50).  Burks et al reported eight 
postoperative ACL infections from a population of 1,918 arthroscopic ACL reconstructions, 
including seven hamstring tendon autografts and only one BTB autograft (20).  One explanation 
for this trend was the relatively short length of hamstring graft places suture material inside the 
joint, which acts as a foreign body predisposing the joint to infections (10). 
 
Diagnosis of infection 
 Prompt diagnosis and treatment of a septic joint is necessary for infection control 
and to achieve best long-term clinical outcomes.  Postoperative infections are classified as either 
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acute (<two weeks), subacute (two weeks to two months) or late (>two months).  Most patients 
have acute or subacute presentation of symptoms (20, 33, 44, 59, 86, 88, 6, 50, 87, 49, 10, 85, 74, 
72).  The most consistent findings include increased pain, inflammation and moderate effusion, 
whereas fevers, chills, erythema and drainage are not consistently present (44, 88, 49, 72).  
While Armstrong et al state that typical postoperative pain usually lasts for only 1-2 days and 
pain lasting longer than this should be suggestive of septic arthritis, there is a high degree of 
patient variability with infected patients generally having more pain than expected (2).  The 
diagnosis of septic arthritis can be difficult to make in the early postoperative period as knee 
swelling, inflammation, and stiffness may be interpreted as normal, making laboratory data 
crucial to establishing the diagnosis.  Laboratory values including erythrocyte sedimentation rate 
(ESR) and C-reactive protein (CRP) are recommended to confirm diagnosis as they have high 
negative predictive values. Wang et al used ESR, CRP, and fibrinogen (FIB) levels more than 50 
mm/h, 6 mg/mL, and 800 mg/mL, respectively, for septic arthritis (87).  Margheritini et al 
believe CRP to be a more accurate predictor of postoperative complications than ESR, as both 
can be elevated postoperatively, but CRP rises and falls more rapidly than ESR levels. A 
sustained elevation of CRP beyond two weeks or new rise should prompt investigation to rule 
out infection (56).  Complete CRP levels normalization is generally seen after 2-12 weeks.  
Synovial fluid aspirate is still  the best diagnostic test for infection (20).  Progressively higher 
synovial WBC counts are seen with septic arthritis; polymorphonuclear cells greater than 90% 
are highly predictive (44).  Magnetic Resonance Imaging (MRI) can substantiate the diagnosis of 
infection in uncertain scenarios, and it can further determine the extent of the infection and detect 
any specific fluid collection.  Findings on imaging can include joint effusion, synovitis, bone 
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erosions, edema of adjacent soft tissues and bone marrow, sinus tracts, and soft tissue abscesses 
(68). 
 
Risk factors for infection 
 Several risk factors common for infection following ACL reconstruction include intra-
articular corticosteroid injection, systemic corticosteroids, immunocompromised state, prior or 
concomitant procedures on the same knee, and history of previous knee infection (88, 49, 62, 1).  
More recent literature suggests other possible risk factors including graft type, operative time, 
tourniquet time, foreign body load, and usage of drains (3, 69, 20, 59, 86, 88, 74, 72, 58, 4).  
Individual reports have implicated methods of sterilization, instrumentation, and specific 
hardware used for graft fixation. Wang et al noted that flash sterilization of instrumentation was 
correlated with high rates of infections (87).  Tuman et al suggested that failure to disassemble a 
“tube-within-a-tube” hamstring harvester may lead to unsatisfactory sterilization, providing a 
potential source for contamination (83).  Judd et al found a higher incidence of infection 
associated with post/washer/braided suture construct in hamstring autograft fixation.  This may 
be related to soft tissue injury during hamstring harvesting combined with relatively 
subcutaneous position of the metallic construct (49).  Eight of 11 patients had concomitant extra-
articular wound infection at this site with cultures positive for the same causative organism. 
 Many different microorganisms have been cultured from synovial fluid of with septic 
arthritis, but the most common pathogen is Staphylococcus aureus.  Causative bacteria also 
include coagulase-negative Staphylococcus, Propionibacter acnes, Peptostreptococcus, 
Enterobacter, Enterococcus, Pseudomonas aeruginosa, Escherichia coli, and Klebsiella (20, 33, 
44, 59, 86, 88, 6, 50, 87, 49, 10, 85, 74, 72).  Methicillin-resistant Staphylococcusaureus 
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(MRSA) were also cultured among patients. (Au:  Reference needed.) More unusual organisms 
have also identified in case reports, including Mycobacterium fortium, Mycobacterium 
tuberculosis, Staphylococcus lugdenesis, Erysipelothrixrhusio pathiae, and fungal species 
Rhizopus, Microsporus and Candida albicans (61, 84, 63, 66, 64).  Establishing the causative 
organism in an intra-articular infection is crucial to predicting prognosis and commencing 
appropriate treatment.  MRSA joint fluid is a virulent organism which typically presents acutely 
and entails greater need for lavage and for graft removal (54).  Given that the majority of 
infections are with skin flora and are associated with concomitant extra-articular sites for 
infection, inoculation may occur at the time of surgery or shortly thereafter.(59, 49) including 
concomitant inside-out meniscus repair (59, 88).  In subacute or late septic knee arthritis, the 
tibial or femoral sites may be infected and spread to the knee joint from hematoma collection in 
the subcutaneous tissue (49, 10, 33, 44).   
 
Treatment of infection 
 Suspected joint infection is an emergency with the two main treatment goals:  protecting 
the articular cartilage and the graft.  In an animal study cartilage test, more than half its 
glycosaminoglycan and collagen within seven days from the onset of infection (78).  Prompt 
intravenous antibiotic therapy to cover the most common organisms (Staphylococcus aureus and 
coagulase-negative Staphylococcus) should be given as soon as laboratory studies and joint fluid 
have been obtained.  A third-generation cephalosporin or vancomycin is recommended (44, 59, 
86, 88, 49, 72).  When there is a strong clinical suspicion, antibiotic therapy should be continued 
even if synovial fluid cultures are negative (44, 86, 72).   
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 There are several options for treatment of post-reconstruction septic arthritis of the knee 
(45).  Barrett and Field recommended joint debridement with graft and hardware removal (9).  
Burks et al recommend arthroscopic graft removal with six weeks of antibiotics, followed by 
early re-implantation within six weeks of completing antibiotic treatment (20).  Open arthrotomy 
with removal of hardware and curettage of tunnels has been recommended (89).  Staging 
treatment with multiple initial debridements followed by placement of antibiotic-pregnated 
polymethylmethacrylate (PMMA) beads, and final re-implantation at 6-8 months may be best 
(74).  A full course of antibiotic treatment may proceed with arthroscopic debridement in case of 
persistent clinical or abnormal laboratory findings (86).  There is an algorithm for the treatment 
of infections based on a series of seven infections in 2,500 ACL reconstructions (88).     
 A survey of Sports Medicine Fellowship Program Directors regarding a standard of care 
for infections found 85% use culture-specific antibiotics and surgical irrigation of the joint with 
graft retention as the initial treatment for infected patellar tendon autografts and 64% for infected 
allografts (58).  For cases resistant to initial treatment, the most common treatment (39%) 
favored continuing IV antibiotics with repeated surgical irrigation and graft retention.  Thirty-
one percent of respondents did recommend a combination of IV antibiotics, hardware removal 
and graft removal in resistant cases.  Overall, graft removal was not considered the standard of 
care for initial treatment; it was chosen for 6% of autografts and 33% of allografts. After graft 
removal, the earliest time interval for revision procedure is was 6 to 9 months. Since there was 
no consensus in the literature, Matava et al concluded that primary infection can be treated with 
culture-specific intravenous antibiotics and surgical joint irrigation with graft retention as the 
initial treatment. 
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Outcomes after infection 
 The outcomes after deep infection after ACL reconstruction are mixed. Complications 
include pain, stiffness, arthrofibrosis, articular cartilage degeneration, and graft weakening or 
failure.  While patients can generally perform pain-free activities of daily living, knee function 
following infection is impaired and results are much less satisfactory than for patients without 
postoperative infections (49).  A full return to athletic activities was not certain, and pain 
followed by arthrofibrosis was the most common causes of unsatisfactory results (49).  In 13 
knees, of which only two had positive cultures, all treated with antibiotics initially, six patients 
failed to improve underwent arthroscopic irrigation and debridement (86).  Of these 13, four had 
pain with stair climbing, three had slight impairment with squatting exercises, and three anterior 
knee pain with activities of daily living.  In contrast, clinical outcomes inferior to control 
subjects without infection appeared to be secondary to damage to the articular cartilage from the 
infection (59).  Four infections with the most significant functional limitations had severe 
bicondylar focal articular surface irregularities at MRI final follow-up. These patients averaged 
12.25 days of inpatient hospital stay for these infections.   
Recently, a long-term follow-up after infection on four of  831 patients that developed 
septic arthritis postoperatively required an average of 2.75 additional procedures for eradication 
(73).  At 17.9 year average follow-up each patient had a decline in SF-36, Lysholm, and IKDC 
scores, and increase in KT-1000 displacement.  Radiographic and MRI studies showed 
progression of arthritis in all patients, as compared to their 36 month follow up.   
 
Conclusion 
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 Patients should be educated about the signs of infection, and surgeons should always err 
on the side of caution to provide early treatment.  Management with antibiotics and debridement 
with graft retention is usually the recommended treatment.  While the diagnosis of an infection 
after reconstruction has significant morbidity, eradication of infection can usually be attained and 
patients may still have a functional knee with a much higher likelihood of osteoarthritis.   
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Table 1.  Infection rate by graft type 
Study (year) Autograft 
(infections / total) 
Allograft 
(infections / total) 
 
Barker et al (2010) 12/177 = 0.44% 6/1349 = 0.68%  
Indelli et al (2002) 4/1400 = 0.29% 2/2100 = 0.10%  
Greenberg et al 
(2010) 
0/221 = 0% 0/640 = 0%  
Garras et al (2012) 2/253 = 0.79% 4/535 = 0.74%  
Katz et al (2008) 2/170 = 1.2% 4/628 = 0.63%  
Wang et al (2009) 20/3978 = 0.50% 1/90 = 1.11%  
Crawford et al (2005) 0/41 = 0% 11/290 = 3.8%  
TOTAL 40/7840 = 0.51% 28/5632 = 0.49% Overall: 68/13472 = 
0.50% 
 
 
